| Literature DB >> 32559259 |
Shabir A Dhar1, Tahir A Dar1, Naseer A Mir1.
Abstract
PURPOSE: Infected nonunion of the forearm bones is a challenge for the orthopedic surgeon on several fronts. The forearm itself is unique as the difficulties include the relation between restoration of shaft length with the anatomy and long-term functional outcome of adjacent joints, and the risk of elbow and wrist stiffness related to prolonged immobilization. The problem of infection is complex due to the presence of bone necrosis, segmental bone loss, sinus tract formation, fracture instability, and scar adhesion of the soft tissues. The ideal management method for these situations is still debated.Entities:
Keywords: Bone grafting; Infected nonunion; Masquelet technique
Year: 2019 PMID: 32559259 PMCID: PMC7001591 DOI: 10.5005/jp-journals-10080-1411
Source DB: PubMed Journal: Strategies Trauma Limb Reconstr ISSN: 1828-8928
Fig. 1Debridement with plating. Cement has been placed in the defect. The Masquelet membrane after cement removal
Fig. 4Infected nonunion of the ulna. Cement placement with fixation. Grafting followed by union at 1 year follow-up
The clinical parameters of the patients
| 1 | 28/M | R/radius | Staph. | 6 | 4 | Vancomycin | 45–0–50 | 45–0–80 | 6 |
| 2 | 36/M | R/radius | Staph. | 8 | 6 | Vancomycin | 40–0–60 | 80–0–80 | 8 |
| 3 | 37/M | L/ulna | Staph. | 12 | 5.5 | Vancomycin | 50–0–55 | 75–0–80 | 8 |
| 4 | 19/M | R/ulna | 14 | 6 | Tobramycin | 60–0–60 | 80–0–70 | 12 | |
| 5 | 38/F | L/ulna | 6 | 4 | Tobramycin | 60–0–60 | 60–0–50 | 6 | |
| 6 | 63/M | R/radius | Staph. | 7 | 3.5 | Vancomycin | 50–0–55 | 70–0–65 | 6 |
| 7 | 42/M | L/radius | Klebs. | 18 | 6 | Tobramycin | 50–0–55 | 75–0–70 | 9 |
| 8 | 23/M | L/ulna | Mixed | 7 | 6 | Vancomycin | 60–0–60 | 80–0–80 | 9 |
| 9 | 31/M | R/ulna | Staph. | 18 | 7 | Vancomycin | 55–0–55 | 75–0–75 | 12 |
| 10 | 54/M | R/radius | 9 | 4 | Tobramycin | 45–0–45 | 60–0–60 | 6 | |
| 11 | 56/M | R/ulna | Staph | 6 | 4.5 | Vancomycin | 50–0–45 | 55–0–70 | 6 |
| 12 | 28/M | L/ulna | 12 | 5 | Tobramycin | 60–0–60 | 80–0–85 | 6 |